Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
7(37%)
Results Posted
113%(9 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_2
2
11%
Ph phase_4
2
11%
Ph phase_3
11
58%
Ph phase_1
2
11%

Phase Distribution

2

Early Stage

2

Mid Stage

13

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
Phase 2Efficacy & side effects
2(11.8%)
Phase 3Large-scale testing
11(64.7%)
Phase 4Post-market surveillance
2(11.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

7

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(8)
Terminated(2)
Other(2)

Detailed Status

Completed8
Recruiting4
Active, not recruiting3
unknown2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
7
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (11.8%)
Phase 22 (11.8%)
Phase 311 (64.7%)
Phase 42 (11.8%)

Trials by Status

completed842%
unknown211%
active_not_recruiting316%
recruiting421%
terminated211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07365995Phase 3

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Recruiting
NCT07221838Phase 4

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Recruiting
NCT06421935Phase 1

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Active Not Recruiting
NCT06091254Phase 3

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Recruiting
NCT03407144Phase 2

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Active Not Recruiting
NCT06091865Phase 3

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Active Not Recruiting
NCT06911502Phase 3

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Recruiting
NCT05401214

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Unknown
NCT03072238Phase 3

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

Completed
NCT02043678Phase 3

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

Completed
NCT04599634Phase 1

Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies

Completed
NCT01471340Phase 4

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)

Completed
NCT02741271Phase 3

Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

Completed
NCT04706741Phase 2

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis

Completed
NCT01200758Phase 3

A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma

Completed
NCT00562965Phase 3

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

Terminated
NCT02613910Phase 3

Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris

Terminated
NCT01217697

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Unknown
NCT00638690Phase 3

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19